Spero Therapeutics Inc (FRA:2HA)
€ 1.222 -0.032 (-2.55%) Market Cap: 65.12 Mil Enterprise Value: 12.44 Mil PE Ratio: 3.91 PB Ratio: 0.89 GF Score: 29/100

Q1 2020 Spero Therapeutics Inc Earnings Call Transcript

May 08, 2020 / 02:00PM GMT
Release Date Price: €11.1
Operator

Thank you for standing by. This is the conference operator. Welcome to the Spero Therapeutics First Quarter 2020 Earnings Conference Call and Corporate Update. (Operator Instructions) The conference is being recorded. (Operator Instructions)

I would now like to turn the conference over to Sharon Klahre, VP of IR and Strategy, please go ahead.

Sharon Klahre
Spero Therapeutics, Inc. - Senior Director of IR

Great. Thank you, operator, and thank you all for participating in today's conference call. Earlier today, Spero Therapeutics released financial results and provided a pipeline review for the first quarter ended March 31, 2020. If you have yet to see the press release, it's available on the Investor page of the Spero Therapeutics website.

Before we begin, I'd like to remind you that some of the information contained in the news release and on this conference call contain forward-looking statements based on our current expectations. Such forward-looking statements are not a guarantee of performance, and the company's actual results could

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot